Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The shedding typically begins three to six months after the onset of rapid weight loss and resolves within six to twelve months as the body adapts to its new metabolic equilibrium
Then quickly insert the needle in at a 90-degree angle
This reprogramming leads to a metabolic shift where a greater proportion of glucose is diverted through glycolysis to produce lactate, instead of being fully oxidized in mitochondria
TRIUMPH-4 (Phase 3, 68 weeks) 12mg dose: 28.7% weight loss (~71 lbs / 32 kg average) 9mg dose: 26.4% weight loss (~64 lbs / 29 kg average) Patients also saw 76% reduction in knee osteoarthritis pain Blood pressure reduced by 14 mmHg on average Source: ClinicalTrials.gov (TRIUMPH-4, NCT05931367) The TRIUMPH Phase 3 program includes 4 trials studying retatrutide for obesity, type 2 diabetes, and cardiovascular outcomes
